MAZE THERAPEUTICS INC (MAZE) Stock Earnings & Estimates
USA - NASDAQ:MAZE - US5787841007 - Common Stock
27.11 USD
+0.61 (+2.3%)
27.11 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 167.5M | -100.00% | 2.125M | ||||
| EBITDA YoY % growth | -107.206M | -94.462M 11.89% | 60.883M 164.45% | -153M -351.30% | -164.22M -7.33% | -191.76M -16.77% | |
| EBIT YoY % growth | -111.026M | -98.551M 11.24% | 57.586M 158.43% | -150.638M -361.59% | -167.56M -11.23% | -188.4M -12.44% | |
| Operating Margin | N/A | N/A | 34.38% | N/A | N/A | -8,865.88% | |
| EPS YoY % growth | N/A | N/A | N/A | -3.29 86.47% | -2.98 9.64% | -2.98 -0.26% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.73 | -0.73 96.04% | -0.74 35.50% | -0.74 3.67% | -0.82 -12.34% | -0.84 -16.07% |
| Revenue Q2Q % growth | -100.00% | |||||
| EBITDA Q2Q % growth | -39.78M -83.85% | -40.8M -54.38% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -37.858M -56.25% | -38.722M -30.26% | -40.566M -34.19% | -41.554M -13.93% | -42.801M -13.06% | -44.041M -13.74% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.77 | -0.87 | 0.10 | 11.81% |
| Q1 2025 Q2Q % growth | -1.15 | -0.77 | -0.38 | -49.66% |
| Q4 2024 Q2Q % growth | -18.32 | 0.46 | -18.78 | -4,091.29% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -100.00% | 2.125M | -2.125M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 7.43% | 20.48% | 12.7% | 13.79% |
| Revenue | N/A | N/A | N/A | -100% |